The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey

Cherubino Di Lorenzo, Gianluca Coppola, Giorgio Di Lorenzo, Martina Bracaglia, Paolo Rossi, Francesco Pierelli

Research output: Contribution to journalArticle

Abstract

Background Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. Methods We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. Results Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). Discussion Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.

Original languageEnglish
Pages (from-to)194-198
Number of pages5
JournalCephalalgia
Volume36
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Cluster Headache
Self Medication
Street Drugs
Therapeutics
Psilocybin
Internet
Surveys and Questionnaires
Sumatriptan
Physician-Patient Relations
Lysergic Acid Diethylamide
Headache Disorders
Cannabinoids
Self-Help Groups
Heroin
Therapeutic Uses
Cocaine
Physicians

Keywords

  • Cluster headache
  • illicit drugs
  • LSA
  • LSD
  • psilocybin

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

The use of illicit drugs as self-medication in the treatment of cluster headache : Results from an Italian online survey. / Di Lorenzo, Cherubino; Coppola, Gianluca; Di Lorenzo, Giorgio; Bracaglia, Martina; Rossi, Paolo; Pierelli, Francesco.

In: Cephalalgia, Vol. 36, No. 2, 01.02.2016, p. 194-198.

Research output: Contribution to journalArticle

Di Lorenzo, Cherubino ; Coppola, Gianluca ; Di Lorenzo, Giorgio ; Bracaglia, Martina ; Rossi, Paolo ; Pierelli, Francesco. / The use of illicit drugs as self-medication in the treatment of cluster headache : Results from an Italian online survey. In: Cephalalgia. 2016 ; Vol. 36, No. 2. pp. 194-198.
@article{1e44a7301c704d48ba6560a80402e034,
title = "The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey",
abstract = "Background Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. Methods We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. Results Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). Discussion Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.",
keywords = "Cluster headache, illicit drugs, LSA, LSD, psilocybin",
author = "{Di Lorenzo}, Cherubino and Gianluca Coppola and {Di Lorenzo}, Giorgio and Martina Bracaglia and Paolo Rossi and Francesco Pierelli",
year = "2016",
month = "2",
day = "1",
doi = "10.1177/0333102415583145",
language = "English",
volume = "36",
pages = "194--198",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - The use of illicit drugs as self-medication in the treatment of cluster headache

T2 - Results from an Italian online survey

AU - Di Lorenzo, Cherubino

AU - Coppola, Gianluca

AU - Di Lorenzo, Giorgio

AU - Bracaglia, Martina

AU - Rossi, Paolo

AU - Pierelli, Francesco

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. Methods We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. Results Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). Discussion Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.

AB - Background Cluster headache (CH) patients often receive unsatisfactory treatment and may explore illicit substances as alternatives. We aimed to explore this use of illicit drugs for CH treatment. Methods We invited CH patients from an Internet-based self-help group to complete a questionnaire regarding their therapeutic use of illicit substances. Results Of the 54 respondents, 29 were classified as chronic and 39 were drug-resistant cases. Fifty patients had previously tried subcutaneous sumatriptan, 40 had tried O2, and 48 had tried at least one prophylactic treatment. All 54 patients specified that they were dissatisfied with conventional treatments. Thirty-four patients had used cannabinoids, 13 cocaine, 8 heroin, 18 psilocybin, 12 lysergic acid amide (LSA), and 4 lysergic acid diethylamide (LSD). Discussion Some patients with intractable CH decided to try illicit drugs concomitantly with cessation of medical care. Most of these patients found suggestions for illicit drug use on the Internet. Many patients seemed to underestimate the judicial consequences of, and had an overestimated confidence in the safety of, such illicit treatments. Physicians are often not informed by patients of their choice to use illicit drugs. This leads to questions regarding the true nature of the physician-patient relationship among dissatisfied CH patients.

KW - Cluster headache

KW - illicit drugs

KW - LSA

KW - LSD

KW - psilocybin

UR - http://www.scopus.com/inward/record.url?scp=84955293002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955293002&partnerID=8YFLogxK

U2 - 10.1177/0333102415583145

DO - 10.1177/0333102415583145

M3 - Article

VL - 36

SP - 194

EP - 198

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

IS - 2

ER -